Evidence map›Paper›PMID 37370362›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Antifungal Properties of Hydrazine-Based Compounds against

Louis Camaioni, Dylan Lambert, Boualem Sendid, Muriel Billamboz, Samir Jawhara

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Natural Compounds with Antifungal Properties againstAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Louis CamaioniCNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, INSERM U1285, F-59000 Lille, France.
Dylan LambertCNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, INSERM U1285, F-59000 Lille, France.
Boualem SendidCNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, INSERM U1285, F-59000 Lille, France.ORCID 0000-0003-1577-7325
Muriel BillambozINSERM, CHU Lille, Institut Pasteur Lille, U1167-RID-AGE-Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, University of Lille, F-59000 Lille, France.ORCID 0000-0003-1486-7206
Samir JawharaCNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, INSERM U1285, F-59000 Lille, France.ORCID 0000-0002-2759-975X
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

Agence Nationale de la Recherche (ANR) in the setting of project "InnateFun" ANR-16-IFEC-0003-05, in the "Infect-ERA" program
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biofilmCaenorhabditis elegans infection modelCandida albicansfungal resistancehydrazine

Identifiers

PMID37370362
PMCPMC10295702
OpenAlexW4380630438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.